Increased odds of death for patients with interstitial lung disease and covid-19: a case-control study

Dexamethasone in Hospitalized Patients with Covid-19

The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477 · see citing works

Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475 · see citing works

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206 · see citing works

Comorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis

Guan, W.-J., Liang, W.-H., Zhao, Y., Liang, H.-R., Chen, Z.-S., Li, Y.-M., Liu, X.-Q., Chen, R.-C., Tang, C.-L., Wang, T., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00547-2020 · Cited by 3,680 · see citing works

Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, march 1-30, 2020

Garg, S., Kim, L., Whitaker, M., O’Halloran, A., Cummings, C., Holstein, R., Prill, M., Chai, S. J., Kirley, P. D., Alden, N. B., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6915e3 · Cited by 2,335 · see citing works

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

Li, X., Xu, S., Yu, M., Wang, K., Tao, Y., Zhou, Y., Shi, J. C., Zhou, M., Wu, B., Yang, Z., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.006 · Cited by 2,237 · see citing works

Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis

Fu, L., Wang, B., Yuan, T., Chen, X., Ao, Y., Fitzpatrick, T., Li, P., Zhou, Y., Lin, Y., Duan, Q., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.041 · Cited by 1,109 · see citing works

Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis

Alqahtani, J. S., Oyelade, T., Aldhahir, A. M., Alghamdi, S., Almehmadi, M., Alqahtani, A., Quaderi, S. A., Mandal, S., & Hurst, J. R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233147 · Cited by 863 · see citing works

Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis

Li, H., Chen, C., Hu, F., Wang, J., Zhao, Q., Gale, R. P., & Liang, Y. (2020) · Leukemia · doi:10.1038/s41375-020-0848-3 · Cited by 265 · see citing works

The Role of Infection in Interstitial Lung Diseases

Azadeh, N., Limper, A. H., Carmona, E. M., & Ryu, J. H. (2017) · Chest · doi:10.1016/j.chest.2017.03.033 · Cited by 115 · see citing works

Patients with interstitial lung disease and pulmonary sarcoidosis are at high risk for severe illness related to COVID-19

Southern, B. D. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.ccc026 · Cited by 30 · see citing works

Risk factors for severe and critically ill COVID‐19 patients: A review

Gao, Y., Ding, M., Dong, X., Zhang, J., Azkur, A. K., Azkur, D., Gan, H. K., Sun, Y., Fu, W., Li, W., et al. (2020) · Allergy · doi:10.1111/all.14657 · Cited by 1,399 · see citing works

Tuning immunity through tissue mechanotransduction

Du, H., Bartleson, J. M., Butenko, S., Alonso, V., Liu, W. F., Winer, D. A., & Butte, M. J. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00761-w · Cited by 435 · see citing works

Idiopathic pulmonary fibrosis: state of the art for 2023

Podolanczuk, A. J., Thomson, C. C., Remy-Jardin, M., Richeldi, L., Martinez, F. J., Kolb, M., & Raghu, G. (2023) · European Respiratory Journal · doi:10.1183/13993003.00957-2022 · Cited by 359 · see citing works

The costs and benefits of senotherapeutics for human health

Raffaele, M., & Vinciguerra, M. (2022) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00300-7 · Cited by 140 · see citing works

Interstitial lung disease increases susceptibility to and severity of COVID-19

Lee, H. J., Choi, H., Yang, B., Lee, S.-K., Park, T. S., Park, D. W., Moon, J., Kim, T., Sohn, J. W., Yoon, H. J., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.04125-2020 · Cited by 115 · see citing works

Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors

Zsichla, L., & Müller, V. (2023) · Viruses · doi:10.3390/v15010175 · Cited by 113 · see citing works

Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity

Fadista, J., Kraven, L. M., Karjalainen, J. M., Andrews, S. J., Geller, F., Initiative, T. C.-1. H. G., Baillie, J. K., Wain, L. V., Jenkins, G. R., & Feenstra, B. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103277 · Cited by 90 · see citing works

The Usefulness of Chest CT Imaging in Patients With Suspected or Diagnosed COVID-19

Machnicki, S. C., Patel, D., Singh, A. K., Talwar, A., Mina, B. A., Oks, M., Makkar, P., Naidich, D. P., Mehta, A. C., Hill, N. S., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.04.004 · Cited by 88 · see citing works

Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases

Chiner‐Vives, E., Cordovilla, R., de la Rosa, D., Clemente, M. M. G., Alonso, J. L. I., Otero, R., de Llano, L. P., Sellares-Torres, J., & de Granda‐Orive, J. I. (2022) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2022.03.011 · Cited by 80 · see citing works

Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease

Gallay, L., Uzunhan, Y., Borie, R., Lazor, R., Rigaud, P., Marchand-Adam, S., Hirschi, S., Israël‐Biet, D., Valentin, V., & Cottin, V. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202007-2638le · Cited by 74 · see citing works

Pulmonary function and COVID-19

Thomas, M., Price, O. J., & Hull, J. H. (2021) · Current Opinion in Physiology · doi:10.1016/j.cophys.2021.03.005 · Cited by 74 · see citing works

Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis

Liu, C., Lee, J., Ta, C., Soroush, A., Rogers, J. R., Kim, J. H., Natarajan, K., Zucker, J. E., Perl, Y., & Weng, C. (2022) · JMIR Public Health and Surveillance · doi:10.2196/35311 · Cited by 69 · see citing works

COVID‐19 immunopathology: From acute diseases to chronic sequelae

Arish, M., Qian, W. G., Narasimhan, H., & Sun, J. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28122 · Cited by 54 · see citing works

Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision

Mackintosh, J. A., Keir, G. J., Troy, L. K., Holland, A. E., Grainge, C., Chambers, D. C., Sandford, D., Jo, H. E., Glaspole, I., WILSHER, M. L., et al. (2024) · Respirology · doi:10.1111/resp.14656 · Cited by 54 · see citing works

Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks

Patrucco, F., Solidoro, P., Gavelli, F., Apostolo, D., & Bellan, M. (2023) · Microorganisms · doi:10.3390/microorganisms11040895 · Cited by 54 · see citing works

Lung fibrosis: Post-COVID-19 complications and evidences

Hirawat, R., Jain, N., Saifi, M. A., Rachamalla, M., & Godugu, C. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109418 · Cited by 52 · see citing works

Update in Interstitial Lung Disease 2020

Podolanczuk, A. J., Wong, A. W., Saito, S., Lasky, J. A., Ryerson, C. J., & Eickelberg, O. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202103-0559up · Cited by 52 · see citing works

Active Smokers Are at Higher Risk of COVID-19 Death: A Systematic Review and Meta-analysis

Patanavanich, R., Siripoon, T., Amponnavarat, S., & Glantz, S. A. (2022) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntac085 · Cited by 50 · see citing works

Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study

Figueroa‐Parra, G., Gilbert, E., Valenzuela-Almada, M. O., Vallejo, S., Neville, M. R., Patel, N. J., Cook, C., Fu, X., Hagi, R., McDermott, G. C., et al. (2022) · The Lancet Rheumatology · doi:10.1016/s2665-9913(22)00227-2 · Cited by 50 · see citing works

A Causal Atlas on Comorbidities in Idiopathic Pulmonary Fibrosis

Zhu, J., Zhou, D., Wang, J., Yang, Y., Chen, D., He, F., & Li, Y. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.02.038 · Cited by 47 · see citing works

Interstitial lung disease before and after COVID-19: a double threat?

Valenzuela, C., WATERER, G. W., & Raghu, G. (2021) · European Respiratory Journal · doi:10.1183/13993003.01956-2021 · Cited by 47 · see citing works

COVID‐19 patients with documented alcohol use disorder or alcohol‐related complications are more likely to be hospitalized and have higher all‐cause mortality

Bailey, K. L., Sayles, H. R., Campbell, J. R., Khalid, N., Anglim, M., Ponce, J., Wyatt, T. A., McClay, J. C., Burnham, E. L., Anzalone, A. J., et al. (2022) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14838 · Cited by 46 · see citing works

Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity

Bui, L. T., Winters, N. I., Chung, M.-I., Joseph, C., Gutierrez, A. J., Habermann, A. C., Adams, T. S., Schupp, J. C., Poli, S., Peter, L. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24467-0 · Cited by 43 · see citing works

COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis

Sinha, S., Castillo, V., Espinoza, C. R., Tindle, C., Fonseca, A. G., Dan, J. M., Katkar, G. D., Das, S., Sahoo, D., & Ghosh, P. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104185 · Cited by 41 · see citing works

Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target

Ntatsoulis, K., Karampitsakos, Τ., Tsitoura, E., Stylianaki, E.-A., Matralis, A. N., Tzouvelekis, A., Antoniou, K. M., & Aidinis, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.687397 · Cited by 39 · see citing works

Combined Pulmonary Fibrosis and Emphysema

Nemoto, M., Koo, C. W., Scanlon, P. D., & Ryu, J. H. (2023) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2023.05.002 · Cited by 39 · see citing works

Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis

Naqvi, S. F., Lakhani, D. A., Sohail, A. H., Maurer, J., Sofka, S., Sarwari, A. R., & Hadi, Y. B. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2021-000969 · Cited by 32 · see citing works

Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells

Nikitopoulou, I., Fanidis, D., Ntatsoulis, K., Moulos, P., Mpekoulis, G., Evangelidou, M., Vassiliou, A. G., Dimakopoulou, V., Jahaj, E., Tsipilis, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810006 · Cited by 26 · see citing works

COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis

Sgalla, G., Magrì, T., Lerede, M., Comes, A., & Richeldi, L. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202112-2765le · Cited by 26 · see citing works

Systemic sclerosis in the time of COVID-19

Hoffmann‐Vold, A., Distler, O., Bruni, C., Denton, C. P., de Vries-Bouwstra, J. K., Matucci‐Cerinic, M., Vonk, M. C., & Gabrielli, A. (2022) · The Lancet Rheumatology · doi:10.1016/s2665-9913(22)00130-8 · Cited by 26 · see citing works

Pre-existing interstitial lung disease in patients with coronavirus disease 2019: A meta-analysis

Ouyang, L., Gong, J., & Yu, M. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108145 · Cited by 23 · see citing works

Risk factors and severity of functional impairment in long COVID: a single-center experience in Croatia

Banić, M., Makek, M. J., Samaržija, M., Muršić, D., Boras, Z., Trkeš, V., Baričević, D., Koršić, M., Basara, L., Glunčić, T. J., et al. (2022) · Croatian Medical Journal · doi:10.3325/cmj.2022.27 · Cited by 23 · see citing works

Longitudinal Analysis of Pulmonary Function Impairment One Year Post-COVID-19: A Single-Center Study

Suppini, N., Firă-Mladinescu, O., Trăilă, D., Motofelea, A. C., Marc, M. S., Manolescu, D., Vaștag, E., Maganti, R. K., & Oancea, C. I. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13081190 · Cited by 22 · see citing works

Update in COVID-19 2020

Chotirmall, S. H., Leither, L. M., Çoruh, B., Chan, L., Joudi, A. M., Brown, S. M., Singer, B. D., & Seam, N. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202102-0415up · Cited by 20 · see citing works

How COVID-19 interacts with interstitial lung disease

Myall, K. J., Martinovic, J. L., & West, A. (2022) · Breathe · doi:10.1183/20734735.0158-2021 · Cited by 21 · see citing works

COVID-19: a new burden of respiratory disease among South African miners?

Naidoo, R. N., & Jeebhay, M. F. (2021) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000759 · Cited by 21 · see citing works

COVID-19 in complex common variable immunodeficiency patients affected by lung diseases

Milito, C., Soccodato, V., Auria, S., Pulvirenti, F., & Quinti, I. (2021) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000789 · Cited by 20 · see citing works

COVID-19 and interstitial lung diseases: A multifaceted look at the relationship between the two diseases

Fukihara, J., & Kondoh, Y. (2023) · Respiratory Investigation · doi:10.1016/j.resinv.2023.05.007 · Cited by 22 · see citing works

Outcomes of Patients with COPD Hospitalized for Coronavirus Disease 2019

Neira, D. A. P., Watts, A., Seashore, J., Duarte, A. G., Nishi, S. P. E., Polychronopoulou, E., Kuo, Y., Baillargeon, J., & Sharma, G. (2021) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.2021.0245 · Cited by 19 · see citing works

Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease

Choi, J. Y., Song, J. W., & Rhee, C. K. (2022) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2021.0141 · Cited by 18 · see citing works

Early COVID-19 lockdown in Greece and idiopathic pulmonary fibrosis: a beneficial “impact” beyond any expectation

Papiris, S. A., Bouros, D. E., Markopoulou, K., Kolilekas, L., Papaioannou, A. Ι., Tzilas, V., Tzouvelekis, A., Fouka, E., Papakosta, D., Daniil, Z. D., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.03111-2020 · Cited by 18 · see citing works

Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic

Favalli, E. G., Maioli, G., Biggioggero, M., & Caporali, R. F. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1908887 · Cited by 18 · see citing works

Characteristics and outcomes of COVID-19 patients with IPF: A multi-center retrospective study

Çilli, A., Hanta, İ., Üzer, F., Çoşkun, F., Sevinç, C., Deniz, P. P., Parlak, M., Altunok, E., Tertemiz, K. C., & Ursavaş, A. (2022) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2022.100900 · Cited by 17 · see citing works

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version

Cottin, V., Bonniaud, P., Cadranel, J. L., Crestani, B., Jouneau, S., Marchand-Adam, S., Nunès, H., Wémeau-Stervinou, L., Bergot, E., Blanchard, É., et al. (2022) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2022.100948 · Cited by 17 · see citing works

The experience of people with idiopathic pulmonary fibrosis living through the COVID‐19 pandemic

Ryan, N., & Meskell, P. (2022) · Journal of Advanced Nursing · doi:10.1111/jan.15187 · Cited by 15 · see citing works

Interstitial lung disease independently associated with higher risk for COVID-19 severity and mortality: A meta-analysis of adjusted effect estimates

Wang, Y., Hao, Y., Hu, M., Wang, Y., & Yang, H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109088 · Cited by 15 · see citing works

Recomendaciones SEPAR sobre la vacuna COVID-19 en las enfermedades respiratorias

Álvarez, F. V., Martínez‐García, M. Á., Jiménez, D. G., Fariñas-Guerrero, F., de Lejarazu-Leonardo, R. O., López-Campos, J. L., Blanco‐Aparicio, M., Royo-Crespo, Í., García‐Ortega, A., García, A. T., et al. (2021) · Open Respiratory Archives · doi:10.1016/j.opresp.2021.100097 · Cited by 15 · see citing works

COVID-19 and Interstitial Lung Disease: Keep Them Separate

Podolanczuk, A. J., & Richeldi, L. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202010-3918ed · Cited by 15 · see citing works

Impact of COVID-19 Infection on Patients with Preexisting Interstitial Lung Disease: A Spanish Multicentre Study

Martínez-Besteiro, E., Molina‐Molina, M., Gaeta, A. M., Aburto, M., Casanova, Á., Bobillo, J. R., Orozco, S., Rojo, R. P., Mayoral, R. G., Ballesteros, B. L.-M., et al. (2023) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2023.01.001 · Cited by 14 · see citing works

Mortality among Patients with COVID-19 and Different Interstitial Lung Disease Subtypes: A Multicenter Cohort Study

Zhao, J. L., Metra, B. M., George, G., Roman, J., Mallon, J., Sundaram, B., Li, M., & Summer, R. S. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202202-137rl · Cited by 14 · see citing works

Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2

Candel, F. J., Barreiro, P., Salavert, M., Cabello, A., Fernández‐Ruiz, M., Pérez‐Segura, P., Román, J. S., Berenguer, J., Córdoba, R., Delgado, R. B., et al. (2023) · Viruses · doi:10.3390/v15071449 · Cited by 13 · see citing works

Recognizing risk factors associated with poor outcomes among patients with COVID-19

Rodriguez‐Miguelez, P., Heefner, A., & Carbone, S. (2023) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2023.01.006 · Cited by 13 · see citing works

Importance of Vaccination against SARS-CoV-2 in Patients with Interstitial Lung Disease Associated with Systemic Autoimmune Disease

Vázquez, N. M., García-Studer, A., Rojas-Gimenez, M., Romero-Barco, C. M., Arija, S. M., Mucientes, A., Velloso-Feijoó, M. L., Godoy‐Navarrete, F. J., Morales-Garrido, P., Redondo‐Rodríguez, R., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092437 · Cited by 12 · see citing works

Clinical Profile and Risk Factors for Severe COVID-19 in Hospitalized Patients from Rio de Janeiro, Brazil: Comparison between the First and Second Pandemic Waves

Amado, L. A., Coelho, W. L. D. C. N. P., Alves, A., Carneiro, V. C. D. S., Moreira, O. D. C., de Paula, V. D., Lemos, A., Duarte, L., Gutman, E., Fontes-Dantas, F., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072568 · Cited by 9 · see citing works

Pulmonary fibrosis and COVID-19

Kramer, D., Hilton, R., & Roman, J. (2023) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2023.07.006 · Cited by 12 · see citing works

Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis

Wallwork, R., Connolly, C. M., Shneyderman, M., McMahan, Z., Mecoli, C. A., Wigley, F., Hummers, L. K., Shah, A. A., & Paik, J. J. (2022) · The Lancet Rheumatology · doi:10.1016/s2665-9913(22)00100-x · Cited by 11 · see citing works

Risk factors for critical COVID-19 illness during Delta- and Omicron-predominant period in Korea; using K-COV-N cohort in the National health insurance service

Lee, K., Go, M. J., Choi, Y. Y., Kim, M.-K., Seong, J., Sung, H. K., Jeon, J., Jang, H., & Kim, M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300306 · Cited by 11 · see citing works

COVID-19 infection in patients with sarcoidosis: susceptibility and clinical outcomes

Kahlmann, V., Manansala, M., Moor, C. C., Shahrara, S., Wijsenbeek, M. S., & Sweiss, N. (2021) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000812 · Cited by 10 · see citing works

CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseases

Chevalier, K., Génin, M., Petit-Jean, T., Avouac, J., Flipo, R., Georgin‐Lavialle, S., Mahou, S. E., Pertuiset, É., Pham, T., Servettaz, A., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1152587 · Cited by 10 · see citing works

Pathophysiological conditions induced by SARS-CoV-2 infection reduce ACE2 expression in the lung

Miura, Y., Ohkubo, H., Nakano, A., Bourke, J. E., & Kanazawa, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1028613 · Cited by 9 · see citing works

Increased Levels of Galectin-3 in Critical COVID-19

Nikitopoulou, I., Vassiliou, A. G., Athanasiou, N., Jahaj, E., Akinosoglou, K., Dimopoulou, I., Orfanos, S. E., Dimakopoulou, V., Schinas, G., Tzouvelekis, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115833 · Cited by 9 · see citing works

Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique – Actualisation 2021. Version intégrale

Cottin, V., Bonniaud, P., Cadranel, J. L., Crestani, B., Jouneau, S., Marchand-Adam, S., Nunès, H., Wémeau-Stervinou, L., Bergot, E., Blanchard, É., et al. (2022) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2022.01.014 · Cited by 9 · see citing works

mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis

Granata, S., Carratù, P., Stallone, G., & Zaza, G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.710543 · Cited by 8 · see citing works

Predictive model for the development of critical coronavirus disease 2019 and its risk factors among patients in Japan

Muto, Y., Awano, N., Inomata, M., Kuse, N., Tone, M., Takada, K., Fujimoto, K., Ueda, A., Hayashi, M., & Izumo, T. (2021) · Respiratory Investigation · doi:10.1016/j.resinv.2021.08.001 · Cited by 8 · see citing works

Malondialdehyde acetaldehyde adduction of surfactant protein D attenuates SARS‐CoV ‐2 spike protein binding and virus neutralization

Muralidharan, A., Bauer, C. D., Katafiasz, D. M., Pham, D., Oyewole, O. O., Morwitzer, M. J., Roy, E., Bailey, K. L., Reid, S. P., & Wyatt, T. A. (2022) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14974 · Cited by 8 · see citing works

The influence of prior use of inhaled corticosteroids on COVID-19 outcomes: A systematic review and meta-analysis

Chen, C., Wang, C., Chen, C.-Y., Wang, Y., Chen, K.-H., Lai, C., Wei, Y., & Fu, P.-K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0295366 · Cited by 7 · see citing works

Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study

Miyashita, K., Hozumi, H., Furuhashi, K., Nakatani, E., Inoue, Y., Yasui, H., Suzuki, Y., Karayama, M., Enomoto, N., Fujisawa, T., et al. (2024) · Respiratory Research · doi:10.1186/s12931-024-02723-3 · Cited by 7 · see citing works

SECCION IX. Síndrome Post COVID-19: complicaciones tardías y rehabilitación

Saavedra, C. (2021) · Infectio · doi:10.22354/in.v25i4.979 · Cited by 8 · see citing works

The Higher Incidence of COVID-19 in Patients With Non-Tuberculous Mycobacterial Pulmonary Disease: A Single Center Experience in Korea

Kim, S. H., Jhun, B. W., Jeong, B., Park, H. Y., Kim, H., Kwon, O. J., & Shin, S. H. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2022.37.e250 · Cited by 6 · see citing works

COVID-19 and protection of vaccination in patients with systemic sclerosis–associated interstitial lung disease

Panopoulos, S., Tzilas, V., Bournia, V.-K., Καραμανάκος, Α., Laskari, K., Bouros, D. E., Tektonidou, M. G., & Sfikakis, P. P. (2022) · Journal of Scleroderma and Related Disorders · doi:10.1177/23971983221143252 · Cited by 6 · see citing works

Mortality in patients with interstitial lung diseases hospitalized by severe or critical COVID-19

Pruneda, A. K. S., Barreto-Rodríguez, J. O., Selman, M., Juárez-Hernández, F., & Buendía-Roldán, I. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02697-w · Cited by 6 · see citing works

Outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs

Yamaya, T., Hagiwara, E., Baba, T., Iwasawa, T., & Ogura, T. (2022) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2022.04.006 · Cited by 6 · see citing works

Pulmonary Fibrosis in the Time of COVID-19

Buendía-Roldán, I., Valenzuela, C., & Selman, M. (2022) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2022.03.007 · Cited by 6 · see citing works

Impact of COVID-19 pneumonia on interstitial lung disease: semi-quantitative evaluation with computed tomography

Doğan, S., Güldiken, G. S., Alparslan, B., Barış, S. A., & Doğan, N. Ö. (2023) · European Radiology · doi:10.1007/s00330-023-09441-2 · Cited by 5 · see citing works

Understanding the telehealth experience of care by people with ILD during the COVID-19 pandemic: what have we learnt?

Tikellis, G., Corte, T. J., Glaspole, I., Goh, N. S. L., Khor, Y. H., Wrobel, J. P., Symons, K., Fuhrmeister, L., Glenn, L. M., Chirayath, S., et al. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02396-6 · Cited by 5 · see citing works

COVID-19 in Patients with Pre-Existing Interstitial Lung Disease: Potential Value of a Steroid-Based Treatment Strategy

Arai, T., Kurahara, Y., Moda, M., Kobayashi, T., Matsuda, Y., Kagawa, T., Sugawara, R., Tsuyuguchi, K., & Inoue, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12154940 · Cited by 5 · see citing works

A Review: The Potential Involvement of Growth Arrest-Specific 6 and Its Receptors in the Pathogenesis of Lung Damage and in Coronavirus Disease 2019

Apostolo, D., Ferreira, L. L., Tizio, A. D., Ruaro, B., Patrucco, F., & Bellan, M. (2023) · Microorganisms · doi:10.3390/microorganisms11082038 · Cited by 5 · see citing works

Navigating the COVID-19 pandemic: Experiences and self-management approaches adopted by people with interstitial lung disease

Tikellis, G., Corte, T. J., Glaspole, I., Goh, N. S. L., Khor, Y. H., Wrobel, J. P., Symons, K., Fuhrmeister, L., Glenn, L. M., Chirayath, S., et al. (2024) · Chronic Respiratory Disease · doi:10.1177/14799731231226236 · Cited by 5 · see citing works

Impact of sarcopenia and obesity on mortality in older adults with SARS-CoV-2 infection: automated deep learning body composition analysis in the NAPKON-SUEP cohort

Schluessel, S., Mueller, B., Tausendfreund, O., Rippl, M., Deißler, L., Martini, S., Schmidmaier, R., Stoecklein, S., Ingrisch, M., Blaschke, S., et al. (2025) · Infection · doi:10.1007/s15010-025-02555-3 · Cited by 5 · see citing works

Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease

Sparks, J. A., Wallace, Z. S., & Robinson, P. C. (2021) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000812 · Cited by 5 · see citing works

The impact of COVID-19 on patients with preexisting interstitial lung disease

Udwadia, Z. F., Koul, P. A., & Dhooria, S. (2021) · Lung India · doi:10.4103/lungindia.lungindia_60_21 · Cited by 5 · see citing works

The occupational syndemics of miners in South Africa

Bulled, N. L., & Singer, M. C. (2024) · Discover Social Science and Health · doi:10.1007/s44155-024-00098-w · Cited by 4 · see citing works

Implementation of facemask sampling for the detection of infectious individuals with SARS-CoV-2 in high stakes clinical examinations – a feasibility study

Pan, D., Williams, C., Decker, J., Fletcher, E., Grolmusova, N., Bird, P. W., Martin, C. A., Nazareth, J., Rahman, L., O’Kelly, K., et al. (2024) · Future Healthcare Journal · doi:10.1016/j.fhj.2024.100175 · Cited by 4 · see citing works

Tocilizumab and Baricitinib for Recovery From Acute Exacerbation of Combined Pulmonary Fibrosis and Emphysema Secondary to COVID-19 Infection: A Case Report

Kai, Y., Matsuda, M., Suzuki, K., Kasamatsu, T., Kajita, A., Uno, K., & Muro, S. (2022) · Cureus · doi:10.7759/cureus.23411 · Cited by 4 · see citing works

Management of fibrotic hypersensitivity pneumonitis

Mullin, M. L. L., Churg, A., & Ryerson, C. J. (2022) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000904 · Cited by 4 · see citing works

Mortality and Its Predictors in COVID-19 Patients With Pre-existing Interstitial Lung Disease

Dutt, N., Shishir, S., Chauhan, N. K., Jalandra, R., Kuwal, A., Garg, P. K., Kumar, D., Vishwajeet, V., Chakraborti, A., Deokar, K. K., et al. (2022) · Cureus · doi:10.7759/cureus.27759 · Cited by 4 · see citing works

Synergistic Detrimental Effects of Cigarette Smoke, Alcohol, and SARS-CoV-2 in COPD Bronchial Epithelial Cells

Muralidharan, A., Bauer, C. D., Katafiasz, D. M., Strah, H. M., Siddique, A., Reid, S. P., Bailey, K. L., & Wyatt, T. A. (2023) · Pathogens · doi:10.3390/pathogens12030498 · Cited by 4 · see citing works

An explainable machine learning-driven proposal of pulmonary fibrosis biomarkers

Fanidis, D., Pezoulas, V. C., Fotiadis, D. I., & Aidinis, V. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.03.043 · Cited by 4 · see citing works

Rationale and design of the SARCoidosis Outcomes in all respiratory Viral Infectious Diseases (SARCOVID) Study

Strykowski, R. K., Patel, D. C., Neto, M. R., Hena, K., Gulati, M., Maier, L. A., & Patterson, K. C. (2022) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2022-001254 · Cited by 3 · see citing works

Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study

Pertzov, B., Shmueli, E., Zvi, H. B., Massarweh, A., Barkan, T., Ness, A., Shostak, Y., Freidkin, L., Shtraichman, O., & Kramer, M. R. (2022) · Respiratory Research · doi:10.1186/s12931-022-02155-x · Cited by 4 · see citing works

Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease

Kelly, C. A. (2022) · The Lancet Rheumatology · doi:10.1016/s2665-9913(22)00256-9 · Cited by 3 · see citing works

A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19

Scotto, R., Lanzardo, A., Buonomo, A. R., Pinchera, B., Cattaneo, L., Sardanelli, A., Mercinelli, S., Viceconte, G., Perrella, A., Esposito, V., et al. (2022) · Vaccines · doi:10.3390/vaccines10122043 · Cited by 4 · see citing works

Respiratory disorders and their association with clinical outcomes in COVID-19: a narrative review of current literature

Venkat, D., & Badr, M. S. (2023) · Annals of Palliative Medicine · doi:10.21037/apm-22-1427 · Cited by 4 · see citing works

Enhanced predictability and interpretability of COVID-19 severity based on SARS-CoV-2 genomic diversity: a comprehensive study encompassing four years of data

Miao, M., Ma, Y.-H., Tan, J., Chen, R., & Men, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-78493-1 · Cited by 5 · see citing works

COVID-19 causing acute deterioration of interstitial lung disease: a case report

Hussain, M. R. K., Kulasekaran, N., Anand, A. M., & Danassegarane, P. R. (2021) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1186/s43055-021-00431-2 · Cited by 3 · see citing works

Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease

Mackintosh, J. A., Lipman, M. C. I., Lowe, D. M., & Renzoni, E. A. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00326-x · Cited by 3 · see citing works

Global burden, trends and projections analysis of interstitial lung disease and pulmonary sarcoidosis in elderly adults (aged 55+ Years) based on GBD 2021

Huang, Z., Xie, T., Tang, M., Chen, Z., Jia, D., Su, A., Jin, Z., Liang, T., & Wei, X. (2026) · PLoS ONE · doi:10.1371/journal.pone.0347482 · Cited by 2 · see citing works

Management of chronic respiratory diseases during viral pandemics: A concise review of guidance and recommendations

Sharma, P., Mishra, M. K., Dua, R., Saini, L. K., & Sindhwani, G. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_974_21 · Cited by 2 · see citing works

SARS-CoV-2-Infektion und interstitielle Lungenerkrankungen – Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin

Behr, J., Berger, M. P., Blum, T. G., Bonella, F., Dinkel, J., Gläser, S., Hagmeyer, L., Kneidinger, N., Koschel, D., Prasse, A., et al. (2023) · Pneumologie · doi:10.1055/a-2007-9845 · Cited by 2 · see citing works

Use of illness severity scores to predict mortality in interstitial lung disease patients hospitalised with acute respiratory deterioration

Williams, R., Hyams, C. J., Robertshaw, J., González, M. G., Szasz-Benczur, Z., White, P., Maskell, N. A., Finn, A. H. R., Barratt, S. L., Adegbite, D., et al. (2023) · Respiratory Medicine · doi:10.1016/j.rmed.2023.107220 · Cited by 2 · see citing works

Interstitial Lung Disease after COVID-19

Cottin, V., Lafitte, C., Sénéchal, A., & Traclet, J. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202006-2466im · Cited by 6 · see citing works

Mortality and Intubation Risk Factors in Patients With Interstitial Lung Disease Infected With COVID-19 in the United States in 2020

Ehteshami‐Afshar, S., Simha, N. L., & Raj, R. (2023) · doi:10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1822

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study

Drake, T. M., Docherty, A. B., Harrison, E. M., Quint, J. K., Adamali, H. I., Agnew, S., Babu, S., Barber, C. M., Barratt, S. L., Bendstrup, E. M., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202007-2794oc · Cited by 226 · see citing works

Mortality among Patients with COVID-19 and Different Interstitial Lung Disease Subtypes: A Multicenter Cohort Study

Zhao, J. L., Metra, B. M., George, G., Roman, J., Mallon, J., Sundaram, B., Li, M., & Summer, R. S. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202202-137rl · Cited by 14 · see citing works

Impact of COVID-19 on Exacerbations and Mortality in Interstitial Lung Disease at Long-term Follow-up: A Nationwide Population-based Cohort Study

Kim, B.-G., Lee, H. J., Jeong, C. Y., Kim, J. S., & Kim, S. H. (2024) · doi:10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a1801